Latest News
News from the FDA/CDC
FDA targets flavored cartridge-based e-cigarettes, but says it is not a ‘ban’
E-cigarette companies that do not follow this guidance within 30 days risk FDA enforcement actions.
From the Journals
Data point to bidirectional link between sleep disorders and ADHD
Investigators found a dose-response relationship between sleep duration and the odds of having ADHD symptoms.
Feature
Vermont tops America’s Health Rankings for 2019
Mississippi wins/loses its annual battle for the bottom with Louisiana.
From the Journals
Dual e-cigarette and combustible tobacco use compound respiratory disease risk
E-cigarettes have been promoted as a safer alternative to combustible tobacco.
FDA/CDC
FDA okays ubrogepant for acute migraine treatment
ACHIEVE I and ACHIEVE II demonstrate efficacy.
Feature
HealthCare.gov enrollment ends with unexpected extension
Trump administration brings stability to “what remains a failed experiment,” the CMS administrator said.
Feature
Appropriations bill, now law, eliminates ACA taxes, raises tobacco age
The appropriations bill includes a number of other health-related provisions, including increasing the minimum age for purchasing tobacco to 21....
News from the FDA/CDC
FDA approves Dayvigo for insomnia
The orexin receptor antagonist will be available in 5-mg and 10-mg tablets after DEA scheduling.
FDA/CDC
FDA approves Caplyta to treat schizophrenia in adults
Advisory panel meeting was canceled in July.
Conference Coverage
First autoimmune epilepsy RCT supports IVIG therapy
BALTIMORE – Misdiagnosis and delayed treatment may mean that patients end up in nursing homes diagnosed with Alzheimer’s disease.
Feature
Appeals court rules ACA’s individual mandate is unconstitutional
The Trump administration chose not to defend the ACA, but it does not seem entirely prepared for what might happen if the law is overturned.